Integrated Filing
IGIL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IGI reported strong Q1 FY26 results with standalone revenue from operations rising ~18.8% YoY to Rs 2,341.30 million (vs Rs 1,971.34 million in Q1 FY25). Standalone profit after tax grew ~43% to Rs 1,374.80 million (vs Rs 961.21 million), with EPS at Rs 3.18. On a consolidated basis, revenue grew ~15.7% YoY to Rs 3,009.12 million while PAT jumped ~62.5% to Rs 1,265.32 million. For H1 FY26 (consolidated), revenue rose ~12.6% to Rs 6,056.95 million and PAT grew ~31% to Rs 2,672.58 million. Auditors MSKA & Associates issued an unmodified review opinion. Operating cash flow remained healthy at Rs 2,551 million (standalone). Of the Rs 1,475 crore IPO proceeds, the full Rs 1,300 crore for the IGI Belgium/Netherlands acquisition has been utilised, with Rs 25.73 crore still pending for general corporate purposes. A new wholly-owned subsidiary, IGI Diamonds and Gemstones Testing Laboratory L.L.C., was incorporated in Dubai.
Strong YoY PAT growth of 40-60% across standalone and consolidated results, combined with margin expansion and positive operating cash flow, signals robust business momentum that should be viewed positively by shareholders. Full deployment of the major IPO acquisition proceeds removes a key overhang.